Year in Review

A Year of Appreciation, Conscious Capital, & Resilience

Thanks to our Limited Partners,
we raised $750M across two new funds

The $475M Mayfield XVI fund will be focused on early-stage investments, and the $275M Select II fund will focus on select early-growth stage investments.

500 IPOs | 500+ Investments | 20 Funds | $2.5B AUM | 200+ M&As

Welcome to new Partner Arvind Gupta on our Engineering Biology Team

Arvind Gupta

Shoutout to our Managing Director Navin Chaddha, who made his 12th appearance on the Forbes Midas List as a Top Five Investor

Navin Chaddha

Kudos to Mammoth Biosciences Co-founder Jennifer Doudna, who received the Nobel Prize in Chemistry for her discovery of CRISPR

Jennifer Doudna

Congratulations to the

3 teams

who aligned with leaders

Congrats to the

11 teams

that raised over $1 billion in follow-on capital

We evangelized the idea of Conscious Capital

We believe it’s time for the venture industry to lead with empathy and think beyond returns.

People First